Total Funding
68
67
Total FundingGrant raised
Growth Score
-3 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
107137
Allero Therapeutics is a biopharmaceutical company.
- Kees Leenhouts: Co-Founder/CTO/COOPast Role: Mucosis, Co-Founder & Chief Scientific Officer
- Emil Pot: Co-Founder & CEO
About the Company
Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders.
Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is
broadly applicable to a range of clinical indications with profound unmet medical need.
